8.00
price up icon0.13%   0.010
after-market Handel nachbörslich: 8.00
loading

Amicus Therapeutics Inc Aktie (FOLD) Neueste Nachrichten

pulisher
06:23 AM

Zacks Research Issues Optimistic Estimate for FOLD Earnings - MarketBeat

06:23 AM
pulisher
05:11 AM

Wellington Management Group LLP Buys 4,497,950 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

05:11 AM
pulisher
04:23 AM

Pictet Asset Management Holding SA Reduces Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

04:23 AM
pulisher
02:58 AM

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat

02:58 AM
pulisher
Apr 01, 2025

Relative Strength Alert For Amicus Therapeutics - Nasdaq

Apr 01, 2025
pulisher
Apr 01, 2025

Amicus Therapeutics (NASDAQ:FOLD) Reaches New 1-Year LowHere's What Happened - MarketBeat

Apr 01, 2025
pulisher
Apr 01, 2025

Amicus Therapeutics stock hits 52-week low at $8.09 By Investing.com - Investing.com Australia

Apr 01, 2025
pulisher
Apr 01, 2025

Amicus Therapeutics stock hits 52-week low at $8.09 - Investing.com India

Apr 01, 2025
pulisher
Mar 31, 2025

How To Trade (FOLD) - news.stocktradersdaily.com

Mar 31, 2025
pulisher
Mar 29, 2025

Amicus Therapeutics (NASDAQ:FOLD) Sets New 52-Week LowShould You Sell? - MarketBeat

Mar 29, 2025
pulisher
Mar 28, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Acquired by Fox Run Management L.L.C. - MarketBeat

Mar 28, 2025
pulisher
Mar 28, 2025

Amicus Therapeutics (NASDAQ:FOLD) Trading Down 2.5%Time to Sell? - MarketBeat

Mar 28, 2025
pulisher
Mar 27, 2025

Is Amicus Therapeutics (NASDAQ:FOLD) A Risky Investment? - simplywall.st

Mar 27, 2025
pulisher
Mar 26, 2025

Intech Investment Management LLC Has $1.18 Million Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Mar 26, 2025
pulisher
Mar 26, 2025

Pompe Disease Treatment Market Size in 7MM is expected to grow at - openPR.com

Mar 26, 2025
pulisher
Mar 25, 2025

Amicus Therapeutics stock hits 52-week low at $8.54 By Investing.com - Investing.com UK

Mar 25, 2025
pulisher
Mar 25, 2025

Semanteon Capital Management LP Purchases 43,288 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Mar 25, 2025
pulisher
Mar 24, 2025

Pompe Disease Treatment Market reached US$ 1.39 billion in 2024 - openPR.com

Mar 24, 2025
pulisher
Mar 24, 2025

Primecap Management Co. CA Sells 94,000 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Mar 24, 2025
pulisher
Mar 22, 2025

Victory Capital Management Inc. Reduces Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Mar 22, 2025
pulisher
Mar 22, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Charles Schwab Investment Management Inc. - MarketBeat

Mar 22, 2025
pulisher
Mar 21, 2025

Amicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue? - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio - Yahoo Finance

Mar 21, 2025
pulisher
Mar 21, 2025

Connor Clark & Lunn Investment Management Ltd. Has $2.85 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Mar 21, 2025
pulisher
Mar 20, 2025

How to Take Advantage of moves in (FOLD) - Stock Traders Daily

Mar 20, 2025
pulisher
Mar 20, 2025

Pompe Disease Treatment Market Size, Potential Scope 2033 By Key - openPR.com

Mar 20, 2025
pulisher
Mar 19, 2025

Amicus Posts Preliminary 2024 Results, Issues 2025 Outlook - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Great Lakes Advisors LLC Lowers Position in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Mar 19, 2025
pulisher
Mar 17, 2025

Is Amicus Therapeutics Inc. (FOLD) the Best Nasdaq Stock Under $20 to Buy Now? - Insider Monkey

Mar 17, 2025
pulisher
Mar 17, 2025

Amicus Therapeutics Is Very Attractive At Current Prices (Rating Upgrade) (NASDAQ:FOLD) - Seeking Alpha

Mar 17, 2025
pulisher
Mar 15, 2025

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Shares Sold by Inceptionr LLC - MarketBeat

Mar 15, 2025
pulisher
Mar 13, 2025

Amicus Therapeutics (NASDAQ:FOLD) Reaches New 52-Week LowTime to Sell? - MarketBeat

Mar 13, 2025
pulisher
Mar 13, 2025

Pompe Disease Treatment Market Size in the 7MM is expected - openPR

Mar 13, 2025
pulisher
Mar 13, 2025

Essex Investment Management Co. LLC Has $2.18 Million Stock Holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - MarketBeat

Mar 13, 2025
pulisher
Mar 12, 2025

Amicus Therapeutics, Inc. (FOLD): Among the Stocks Under $10 With High Upside Potential - Insider Monkey

Mar 12, 2025
pulisher
Mar 10, 2025

Amicus Therapeutics at Leerink Conference: Path to Profitability By Investing.com - Investing.com Canada

Mar 10, 2025
$67.48
price down icon 1.23%
$73.33
price down icon 0.15%
$31.79
price up icon 1.63%
$18.91
price down icon 7.58%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 3.81%
Kapitalisierung:     |  Volumen (24h):